Article Details

Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA ... - BioSpace

Retrieved on: 2022-11-08 22:09:24

Tags for this article:

Click the tags to see associated articles and topics

Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA ... - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/immunomic-therapeutics-receives-fda-fast-track-designation-for-iti-3000-a-pdna-vaccine-in-development-for-the-treatment-of-merkel-cell-carcinoma/

Excerpt

Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up